GERMANY- EW Nutrition, a leading provider of functional animal nutrition solutions, has announced the acquisition of the Biomin BioStabil silage inoculant product line from dsm-Firmenich to bolster its presence in the animal nutrition sector. 

The deal marks a significant expansion for EW Nutrition, granting ownership of a well-established and successful line of silage inoculants.

Jan Vanbrabant, CEO of EW Nutrition, expressed enthusiasm about the acquisition, stating, “The agreement we have concluded gives us a solid foothold in a sector where we are currently developing a more substantial presence. EW Nutrition continues to expand strategically, enriching its portfolio with market-leading solutions, developed in-house or through acquisitions.

Vanbrabant highlighted the strategic importance of the Biomin BioStabil line, emphasizing its compatibility with EW Nutrition’s vision for growth. “This solid, well-proven line of silage inoculants will be an important addition to customers of EW Nutrition’s On-Farm Solutions business around the world,” he added.

The acquisition transaction was finalized on March 1, 2024. As part of the agreement, EW Nutrition will provide active support to all customers in the transition period, ensuring continuity of service. 

Over the coming months, the asset, brand, and go-to-market strategy will be seamlessly integrated into EW Nutrition’s operations.

While the financial terms of the acquisition remain confidential, the move signifies EW Nutrition’s commitment to expanding its product offerings and enhancing its market position. 

The company has seen notable growth in recent years, with key acquisitions such as Ventar D and Pretect D, solidifying its reputation as a leading provider of animal nutrition solutions.

With the addition of the Biomin BioStabil line, EW Nutrition aims to further strengthen its portfolio and continue delivering innovative solutions to meet the evolving needs of its global customer base.

This news comes about a month after dsm-Firmenich announced plans to separate its Animal Nutrition & Health (ANH) division from the broader group, aimed at insulating itself from the volatile vitamins market. 

This decision underscores the company’s commitment to focusing on nutrition, health, and beauty segments while safeguarding against earnings fluctuations triggered by the downturn in the vitamins sector.

According to the company, the ANH division, led by Ivo Lansbergen since 2019, is slated to operate under a distinct ownership structure, with various options currently under consideration.

For all the latest grains industry news from Africa, the Middle East, and the World, subscribe to our weekly NEWSLETTERS, follow us on LinkedIn, and subscribe to our YouTube channel.